Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.3500 (0%) ($0.0000 - $0.0000) on Wed. Mar. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.85% (three month average) | RSI | 32 | Latest Price | $7.3500(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -11.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) LIT(13%) XLB(13%) IPO(12%) BOTZ(11%) ONLN(11%) | Factors Impacting ANPC price | ANPC will decline at least -2.925% in a week (0% probabilities). SHY(-8%) VIXM(-5%) VXX(-4%) TBT(-3%) TLT(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.925% (StdDev 5.85%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.73(-273.2%) | Resistance Level | $8.75 | 5 Day Moving Average | $7.29(0.82%) | 10 Day Moving Average | $7.99(-8.01%) | 20 Day Moving Average | $8.75(-16%) | To recent high | -34.7% | To recent low | 4% | Market Cap | $63m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |